InvestorsHub Logo
icon url

PNW_Ironman

02/05/22 4:49 PM

#202688 RE: Scooter McCabe #202687

Apparently not low enough for Lenzilumab. Pffft.
icon url

SF Anony

02/05/22 5:00 PM

#202690 RE: Scooter McCabe #202687

The same Remdesivir that a very large global study showed was essentially useless against COVID. So, it damages the liver and doesn't provide benefit. Yet it was given EUA by the FDA, based on data from Fauci's NAIAD.

Wasn't the original question about corruption in the government regulatory complex? Because Remdesivir's story sure sounds like corruption.

"At best, one large, well-designed study found remdesivir modestly reduced the time to recover from COVID-19 in hospitalized patients with severe illness. A few smaller studies found no impact of treatment on the disease whatsoever. Then, on 15 October—in this month's decidedly unfavorable news for Gilead—the fourth and largest controlled study delivered what some believed was a coup de grâce: The World Health Organization's (WHO's) Solidarity trial showed that remdesivir does not reduce mortality or the time COVID-19 patients take to recover."

https://www.science.org/content/article/very-very-bad-look-remdesivir-first-fda-approved-covid-19-drug